1. Home
  2. PED vs ACET Comparison

PED vs ACET Comparison

Compare PED & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pedevco Corp.

PED

Pedevco Corp.

N/A

Current Price

$0.81

Market Cap

56.7M

Sector

Energy

ML Signal

N/A

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$7.15

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PED
ACET
Founded
N/A
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.7M
69.6M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
PED
ACET
Price
$0.81
$7.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$1.50
$65.33
AVG Volume (30 Days)
674.6K
134.8K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.82
EPS
N/A
N/A
Revenue
$39,553,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$305.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
28.49
N/A
52 Week Low
$0.43
$0.45
52 Week High
$0.85
$9.05

Technical Indicators

Market Signals
Indicator
PED
ACET
Relative Strength Index (RSI) 65.43 50.18
Support Level $0.54 $6.54
Resistance Level $0.82 $8.46
Average True Range (ATR) 0.08 0.47
MACD 0.02 -0.03
Stochastic Oscillator 85.57 38.28

Price Performance

Historical Comparison
PED
ACET

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: